Why did Wall Street climb after Fed's Bowman comments?
How will Tesla's robotaxi launch impact its stock?
What effect could Iran close Strait of Hormuz have?
Why is Kroger closing dozens of stores?
How are US-Iran tensions affecting oil prices?
What caused Fiserv's stock surge with stablecoin move?
Why is Compass suing Zillow over home listings?
Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars
benzinga.com/news/health-care/25/06/46053581/exelixis-targets-5-billion-in-sales-with-promising-data-in-key-colorectal-cancer-drug-trial-stoc
On Sunday, Exelixis, Inc. (NASDAQ:EXEL) revealed topline results from the STELLAR-303 phase 3 pivotal trial of zanzalintinib (100 mg) combined with atezolizumab.
The study includes patients with previously treated non-microsatellite instability (MSI)-high metastatic colorectal cancer…
This story appeared on benzinga.com, 2025-06-23 14:37:05.